-
what is pharmacology
study of drugs. drug is any substance or chemical that affects processes of an organism.
-
names of drugs
generic: short, simple
trade: registered, patent
chemical: molecular structure and chemistry
-
-
-
triptans
serotonin agonists
-
prazoles
proton pump inhibitors for GERD
-
olols, alols, ilols
Beta blockers
-
dipines
calcium channel blockers
-
tidines
H2 blockers (histamine 2)
-
zepams or zolams
benzodiazepines
-
statins
lower LDL cholesterol
-
Drug forms
- -tablets: timed, enteric coated, sustained release:
- -capsules
- -troches/lozenges
- -solutions/suspensions: more rapid oral
- -suppositories
- -emulsions
- -topical: dermatological or patches: delayed act
- -implants
- -IV: full effect asap
- Inhalants : fast act
-
Drug Routes
- -Enternal
- -paternal: IV SQ IM ID
- - intrathecal
- - transdermal
- - inhalation
- -topical: eye skin, ears, nose, vaginal
-
Five rights plus Five
-Right patient, drug, dose, time, route
- -Right documentation
- -Right assessment: each med has something that MUST be assessed before med given
- -Right education: why giving
- -Right evaluation
- Right to refuse
-
Passive diffusion (drug movement)
moving from area of higher concentration to area of lower concentration- no energy required
-
facilitated diffusion (drug movement)
same as passive diffusion however the drug is carried by an enzyme of protein
-
Active transport ( drug movement)
moving from area of lower concentration to area of higher concentration (against the concentration gradient) and REQUIRES ENERGY
-
Drug Movements
LIPID soluble drugs cross the cell membrane better than water
LIPID soluble drugs cross cell membranes by dissolving in lipid layer
WATER soluble cross thru via pores and channels
-
Pharmacokinetics
what the body does to a drug
-
Four Phases of Pharmacokinetics
- Absorption
- Distribution
- Metabolism/biotransformation
- Excretion/elimination
-
Absorption
movement of drug particles from the time it enters the body until it is in the bloodstream
-
absorption depends on:
- -Dosage form/route
- -GI: function, pH, presence of food (usually empty stomach improves absorption)
- -Drug soluble and ionization (drugs that are lipid soluble and nonionized are absorbed faster)
-
what affects absorption
blood flow, pain, stress, hunger, fasting, food, disease, pH of stomach acid, poor circulation, route of administration
-
Bioavailability
percentage of an administered drug that is available in the body to produce an effect
- Oral: bioavailability ALWAYS <100%
- IV: bioavailability is 100%
- IM/SC: high availability
-
Factors which alter Bioavailability
- -Drug form & route
- -GI mucosa & motility
- -Food & other drugs
- -changes in liver metabolism
-
First Pass Effect
- -Rapid inactivation (by rapid metabolism) of some oral drugs by the liver before reaching the systemic circulation
- -reduce amount of available drug
- -avoid by using different route
- Must consider when changes route (iv to po, po to iv)
-
Distribution
- -process by which a drug is moved from the circulation to its site of action
- -areas of rapid distribution: heart, liver, kidneys, brain
- -areas of slow distribution: muscle, skin, fat
-
Distribution influenced by:
- -blood flow
- -water soluble vs. fat soluble (slower)
- -blood-brain barrier
- -protein-binding protein
-
Distribution: PROTEIN BINDING:
- -Drug attaches to blood proteins
- -unattached drug is free to act
- -allows storage & release of drug as needed- >longer duration of action
- -reduces risk of toxicity
- -source of drug interactions: competition for binding sites
-
Metabolism/Biotransformation
- -process by which body inactivates drugs
- -increased or decreased toxicity
- -primary site is the liver
- -drugs inactivated by liver enzymes to: inactive metabolites, water-soluble substances, active metabolites
-
Biotransformation influenced by:
age, body weight, genetics, metabolic rate, illness, tolerance, dependence, enzyme induction, nutrition status, drug competition, first pass effect, half life, concurrent use of other drugs
-
factors that decrease metabolism
enzyme inhibitor, liver function, cardiovascular dysfunction, renal dysfunction, starvation. erythromycin or ketoconazole drug therapy
-
factors that increase metabolism
enzyme inducer, barbiturate therapy, rifampin therapy
-
Delayed drug metabolism results in:
- -accumulation of drugs
- -prolonged action of the drugs
-
stimulating drug metabolism causes:
-Diminished pharmacologic effects
-
Excretion
Elimination of drug and metabolites from body
-
Elimination routes:
- GI tracts
- Kidneys
- skin
- breathing
- saliva
- half life
-
Half Life
- -the time it takes for one half of the original amount of a drug in the body to be removed
- -a measure of the rate at which drugs are removed from the body which is determined by the rate of metabolism & excretion
- -most drugs effectively removed after about five half lives
- -determines dose amt & frequency
-
Pharmacodynamics
drug effects, what the drug does to the body
-
therapeutic action
drug doing what is expected
-
onset of action
time drug takes to get to point to start working
-
MEC (minimum effective concentration)
when drug starts working
-
Peak of action
highest level of drug
-
duration of action
level sufficient to elicit a therapeutic response
-
drug effects
- -peak and trough levels
- -therapeutic index
-
bolus vs. loading dose
bolus: drug administered by rapid injection
loading: drug dose given to achieve rapid MEC
-
Receptor Sites
Drug binds with receptor on cell
Receptors are proteins on cell surfaces
-
-
-
nonselective drugs
work on different areas
-
nonspecific drugs
different areas regards to receptor sites
-
side effects
- -Predictable, well known reactions that result in little or n change in patient management
- -predictable frequency
- -occurrences are related to the size of the dose
- -usually resolve when the drug is discontinued
-
adverse drug events (ADE)
-any undesirable/nonpredicted event involving meds
-
Drug Interactions
- Drug-food
- drug-lab
- drug induced photosensitivity
- OTC
- additive effect
- synergistric effector potentiation
- antagonistic effect- blocks effect
- incompatability
-
OTC DRUGs
- Categories:
- -category I- safe & effective
- -category II- unsafe & ineffective
- -category III- insufficient date to judge
-
Pregnancy considerations
changes in physiology d/t hormonal influences, growth of fetus, mothers physical adaption to changes
-
tetratogenicity
- ability of a substance to interfere with fetal development
- drugs categorized as A, B, C,D, and X
- D and especially X are not to be given... effects fetus
-
FDA (Food, Drug & Cosmetic ACT)
monitor and regulate the manufacture and marketing of drugs
-
controlled substance act
designed to remedy the problem of drug abuse with several provision
-
schedule I
- -high potential for drug abuse no accepted medical use
- -ex. heroin, hallucinogens
-
schedule II
- -high potential for drug abuse. accepted medical use. can lead to physical/psychological dependency
- -ex. demerol, morphine, hydrocodone, codeine, oxycodone
-
schedule III
- -medically excepted drugs. may cause dependence. less likely for abuse
- -ex. codeine preparations, non narcotic drugs
-
schedule IV
- -medically accepted drugs, may cause dependence
- -ex phenobarbital, benzodiazepines (diazepam, lorazepam)
-
schedule V
- -medically accepted drugs. very limited potential for dependence
- -opioid-controlled substances for diarrhea and cough
-
nurse practice act
each state has own, which contain laws regarding drug administration by nurses
-
transcultural nursing
traditional (tea, herb), complimentary health, alternative health, mainstream health practices
-
basic ethical principles
informed consent, communication, space, social organization, time, environmental control, biological variations
-
human clinical experiment
- -phase one: to determine human dosage range based on healthy subjects and identity, pharmacokinetics
- -phase two: to demonstrate safety and efficiency of drugs in subjects with disease to be treated
- -phases three and four: to demonstrate safety and efficiency of drug for well client population to include long term data if a chronic regimen
-
pharmacogenetics
effect of a drug that varies from the predicted response due to genetic factors
|
|